WuXi AppTec (OTCMKTS:WUXIF – Get Free Report) is projected to issue its resultson Monday, August 3rd. Analysts expect the company to announce earnings of $0.2319 per share and revenue of $1.9093 billion for the quarter.
WuXi AppTec Stock Performance
Shares of OTCMKTS:WUXIF opened at $22.70 on Monday. WuXi AppTec has a 1 year low of $13.54 and a 1 year high of $22.70. The firm has a fifty day moving average price of $18.40 and a 200 day moving average price of $15.88.
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides end-to-end solutions spanning discovery biology, medicinal chemistry, preclinical safety assessment, clinical trial support, and large-scale manufacturing of small molecules, biologics and advanced therapies. By integrating scientific expertise with state-of-the-art laboratory and production facilities, WuXi AppTec enables clients to accelerate the development of new treatments while managing time and cost pressures.
Key service offerings include custom synthesis and process research for active pharmaceutical ingredients (APIs), biologics development and manufacturing, cell line development, gene therapy support, as well as comprehensive analytical and testing services.
Further Reading
- Five stocks we like better than WuXi AppTec
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
